FATCOIN Market Cap Exceeds $40M, Rises Over 300% in 24 Hours

iconKuCoinFlash
Share
AI summary iconSummary
On-chain data shows FATCOIN’s market cap briefly exceeded $40 million on September 5, reaching $35.34 million with a 24-hour surge of over 300%. The token, issued on the o1 platform, is linked to tokenized shares of Eli Lilly (LLY) via Robinhood. On-chain analysis reveals strong buying activity and liquidity inflows, reflecting rapid trader interest in the asset.

BlockBeats report, September 5: According to GMGN market data, FATCOIN's market cap briefly surpassed $40 million, setting a new high, and is currently trading at $35.34 million, up more than 300% in a single day.


FATCOIN is issued on the o1 platform and paired with tokenized U.S. stocks of Eli Lilly (LLY), the leading weight-loss drug, via the stock trading platform Robinhood.


BlockBeats Note: Stock Meme is an emerging trend that directly combines traditional meme coins with tokenized U.S. stocks: instead of being paired with USDT or ETH, meme coins are now paired directly with on-chain tokenized stocks (such as NVDA, TSLA, AAPL, etc.). This retains the high volatility and community-driven speculative nature of meme coins while leveraging the popularity and narratives of real stocks. Trading fees are often partially funneled back into a community treasury to accumulate the corresponding tokenized stocks, creating a dual driver model of “emotional hype + real asset backing.” Prices are highly volatile—invest with caution.

Disclaimer: The information on this page may have been obtained from third parties and does not necessarily reflect the views or opinions of KuCoin. This content is provided for general informational purposes only, without any representation or warranty of any kind, nor shall it be construed as financial or investment advice. KuCoin shall not be liable for any errors or omissions, or for any outcomes resulting from the use of this information. Investments in digital assets can be risky. Please carefully evaluate the risks of a product and your risk tolerance based on your own financial circumstances. For more information, please refer to our Terms of Use and Risk Disclosure.